SCHEMBL6174642

SCHEMBL6174642

CC(c1ccncc1NC(=O)c1cccc(Cl)c1)C1(C(C)c2ccncc2NC(=O)c2cccc(Cl)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
ABL1 P00519 10/20 0.40
LIPE Q05469 1/20 0.40
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSD17B13 Q7Z5P4 1/20 0.38
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
NTRK1 P04629 1/20 0.37
BRAF P15056 1/20 0.37
GRM5 P41594 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175217 0.91 GAA (0.42) ALDH1A1ABL1LIPECYP3A4GAA
SCHEMBL6174515 0.91 ALDH1A1 (0.45) ALDH1A1ABL1CYP3A4GAACYP2C9
SCHEMBL6173219 0.87 ALDH1A1 (0.38) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172977 0.87 CYP3A4 (0.43) ALDH1A1ABL1CYP3A4GAACYP2C9
SCHEMBL6174469 0.86 TDP1 (0.42) ALDH1A1ABL1LIPECYP3A4GAA
SCHEMBL6173454 0.85 CYP2C9 (0.41) ALDH1A1LIPECYP3A4GAACYP2C9
SCHEMBL6172844 0.84 CYP3A4 (0.40) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6173479 0.83 ALDH1A1 (0.44) ALDH1A1ABL1CYP3A4GAACYP2C9
SCHEMBL6173257 0.83 GRM5 (0.45) ALDH1A1ABL1LIPENTRK1BRAF
SCHEMBL6175907 0.82 ALDH1A1 (0.39) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed